Related references
Note: Only part of the references are listed.Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation
Robert Colebunders et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long-standing nodding syndrome: A case-control study
Rodney Ogwang et al.
EPILEPSIA OPEN (2021)
Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
An Hotterbeekx et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy
An Hotterbeekx et al.
PATHOGENS (2020)
Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells
Mia Levite et al.
JOURNAL OF AUTOIMMUNITY (2020)
A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy
Cedric B. Chesnais et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
HMGB-1, TLR4, IL-1R1, TNF-α, and IL-1β: novel epilepsy markers?
Tulay Kamasak et al.
EPILEPTIC DISORDERS (2020)
High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
Deby Mukendi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers
Zuzana Liba et al.
PLOS ONE (2019)
Neuroinflammation and Not Tauopathy Is a Predominant Pathological Signature of Nodding Syndrome
An Hotterbeekx et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
Baseline characterization of epilepsy in an onchocerciasis endemic area of the Democratic Republic of Congo
Kevin G. Burfeind et al.
BRAIN RESEARCH BULLETIN (2019)
Nodding syndrome in Uganda is a tauopathy
Michael S. Pollanen et al.
ACTA NEUROPATHOLOGICA (2018)
IL-6 is required for protective immune responses against early filarial infection
Muhsin Muhsin et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2018)
The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study
Cedric B. Chesnais et al.
LANCET INFECTIOUS DISEASES (2018)
Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus
Tory P. Johnson et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta
Michael X. Hernandez et al.
ASN NEURO (2017)
Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections
Xin You Tai et al.
BRAIN (2016)
Inflammatory mediators in human epilepsy: A systematic review and meta-analysis
Evelien E. de Vries et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
The role of complement in neurological and neuropsychiatric diseases
Bryan Paul Morgan
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania
Rebekka Koenig et al.
PARASITOLOGY (2010)
Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy
C. S. Mai et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Onchocerca volvulus microfilariae avoid complement attack by direct binding of factor H
T Meri et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Onchocerca volvulus -: Exposed persons fail to produce interferon-γ in response to O-volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density
NW Brattig et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Share Paper
